Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanoma
Open Access
- 10 April 2023
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 41 (4) , 791-806.e4
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (P01 CA167575, R01 CA 227505-03, R01 CA 243486-02, R01 CA 244936-02, R01 CA 231295-03, R35 CA197633)
- National Cancer Institute (P30 CA008748)
- Cancer Research Institute
- V Foundation for Cancer Research
- NYU Langone Medical Center
- Parker Institute for Cancer Immunotherapy
- Weill Cornell Medicine
- Melanoma Research Alliance
- New York University Grossman School of Medicine
- New York University
- Bristol-Myers Squibb
- AstraZeneca
This publication has 63 references indexed in Scilit:
- HTSeq—a Python framework to work with high-throughput sequencing dataBioinformatics, 2014
- From FastQ Data to High‐Confidence Variant Calls: The Genome Analysis Toolkit Best Practices PipelineCurrent Protocols in Bioinformatics, 2013
- Strelka: accurate somatic small-variant calling from sequenced tumor–normal sample pairsBioinformatics, 2012
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencingGenome Research, 2012
- SomaticSniper: identification of somatic point mutations in whole genome sequencing dataBioinformatics, 2011
- CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in HumansClinical Cancer Research, 2011
- Molecular signatures database (MSigDB) 3.0Bioinformatics, 2011
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009